Investor Relations

Subscribe to our News Dispatch Service

* indicates required



Latest Press Releases

Sernova’s Cell Pouch Regenerative Medicine Clinical Trial for Patients with Type 1 Diabetes Supported with Continuous Glucose Monitoring Systems / February 22, 2018


Sernova to Participate at the Biotech Showcase 2018 Healthcare Partnering Conference / January 05, 2018


Sernova Receives US FDA IND Allowance to Initiate a US Clinical Trial of its Cell Pouch for the Treatment of Type 1 Diabetes / December 11, 2017

All Press Releases →


Latest Updates


2018 Annual General Meeting (AGM) - Circular Document - / April 04, 2018


2018 Annual General Meeting (AGM) - Proxy Document - / April 04, 2018


2018 Financial Report - 1st Quarter - / March 29, 2018


2018 Management Discussion & Analysis (MD&A) - 1st Quarter - / March 29, 2018


Clearance by FDA of Sernova's US IND - Conference call audio recording / December 11, 2017


Sernova Fact Sheet - / September 11, 2017


Sernova's 2017 Corporate Presentation - PDF Presentation / September 11, 2017

All Updates →

    Back to Videos

    2018 Management Discussion & Analysis (MD&A) - 1st Quarter


    2018 / Mar 29




    Latest Updates

    Watch videos and presentations

    December 11, 2017

    Clearance by FDA of Sernova's US IND

    Conference call audio recording

    Open

    September 11, 2017

    Sernova Fact Sheet

    Open

    September 11, 2017

    Sernova's 2017 Corporate Presentation

    PDF Presentation

    Open

    AGM Documents

    Please download the related documents

    2018 Sernova AGM Circular document

    PDF file

    Open

    2018 Sernova AGM Proxy document

    PDF file

    Open

    Corporate Governance

    Please read the related documents

    Insider Trading Compliance Policy

    PDF file

    Open

    Whistleblower Policy

    PDF file

    Open

    Analyst Coverage

    Sernova and its securities are covered by the following investment firms. This list of investment firms is being provided solely for your information and convenience and does not constitute an endorsement of or concurrence with any information, opinions, estimates, forecasts or recommendations provided by any of the investment firms listed below by Sernova. Furthermore, Sernova does not distribute information or reports prepared by analysts. The following list includes analysts currently known by Sernova Corp. to follow the company but may not be complete or up to date and may change without notice. Sernova undertakes no obligation to update and maintain this list. Please refer to the Legal Notice on this website for further information.



    Analyst

    Douglas Loe

    Firm

    Echelon Wealth Partners

     

    Stock Price

    For historical charts please visit:


    http://finance.yahoo.com.

    Please Note: All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Sernova nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.